Annual Accounts Receivable
$2.55 M
+$640.21 K+33.48%
December 31, 2023
Summary
- As of March 13, 2025, SBFMW annual accounts receivable is $2.55 million, with the most recent change of +$640.21 thousand (+33.48%) on December 31, 2023.
- During the last 3 years, SBFMW annual accounts receivable has risen by +$2.55 million (+133113.05%).
- SBFMW annual accounts receivable is now at all-time high.
Performance
SBFMW Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$3.22 M
-$754.87 K-19.00%
September 30, 2024
Summary
- As of March 13, 2025, SBFMW quarterly accounts receivable is $3.22 million, with the most recent change of -$754.87 thousand (-19.00%) on September 30, 2024.
- Over the past year, SBFMW quarterly accounts receivable has stayed the same.
- SBFMW quarterly accounts receivable is now -19.00% below its all-time high of $3.97 million, reached on June 30, 2024.
Performance
SBFMW Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
SBFMW Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +33.5% | 0.0% |
| 3 y3 years | +10000.0% | +10000.0% |
| 5 y5 years | +2588.0% | +10000.0% |
SBFMW Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -19.0% | >+9999.0% |
| 5 y | 5-year | at high | >+9999.0% | -19.0% | -100.0% |
| alltime | all time | at high | -100.0% | -19.0% | -100.0% |
Sunshine Biopharma Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.22 M(-19.0%) |
| Jun 2024 | - | $3.97 M(+40.5%) |
| Mar 2024 | - | $2.83 M(+10.8%) |
| Dec 2023 | $2.55 M(+33.5%) | $2.55 M(+25.5%) |
| Sep 2023 | - | $2.03 M(+1.1%) |
| Jun 2023 | - | $2.01 M(+12.3%) |
| Mar 2023 | - | $1.79 M(-6.4%) |
| Dec 2022 | $1.91 M(>+9900.0%) | $1.91 M(>+9900.0%) |
| Sep 2022 | - | $22.00(-8.3%) |
| Jun 2022 | - | $24.00(0.0%) |
| Mar 2022 | - | $24.00(-99.7%) |
| Dec 2021 | $7798.00(+307.0%) | $7798.00(+590.7%) |
| Sep 2021 | - | $1129.00(>+9900.0%) |
| Jun 2021 | - | $0.00(0.0%) |
| Mar 2021 | - | $0.00(-100.0%) |
| Dec 2020 | $1916.00(+345.6%) | $1916.00(>+9900.0%) |
| Sep 2020 | - | $0.00(0.0%) |
| Jun 2020 | - | $0.00(0.0%) |
| Mar 2020 | - | $0.00(-100.0%) |
| Dec 2019 | $430.00(-99.5%) | $430.00(>+9900.0%) |
| Sep 2019 | - | $0.00(-100.0%) |
| Jun 2019 | - | $1023.00(-99.1%) |
| Mar 2019 | - | $119.20 K(+25.5%) |
| Dec 2018 | $94.95 K(+882.3%) | $94.95 K(-7.7%) |
| Sep 2018 | - | $102.89 K(-35.4%) |
| Jun 2018 | - | $159.23 K(+72.3%) |
| Mar 2018 | - | $92.39 K(+855.7%) |
| Dec 2017 | $9667.00(>+9900.0%) | $9667.00(>+9900.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2016 | - | $1006.00(>+9900.0%) |
| Jun 2016 | - | $0.00(-100.0%) |
| Mar 2016 | - | $103.16 K(+3215.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $3111.00(>+9900.0%) | $3111.00(>+9900.0%) |
| Sep 2015 | - | $0.00(-100.0%) |
| Jun 2015 | - | $1933.00(>+9900.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2012 | - | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | - |
| Oct 2009 | - | $0.00(0.0%) |
| Jul 2009 | - | $0.00(0.0%) |
| Apr 2009 | - | $0.00(0.0%) |
| Jan 2009 | - | $0.00(0.0%) |
| Oct 2008 | - | $0.00(0.0%) |
| Jul 2008 | $0.00(0.0%) | $0.00(0.0%) |
| Apr 2008 | - | $0.00(0.0%) |
| Jan 2008 | - | $0.00(0.0%) |
| Oct 2007 | - | $0.00 |
| Jul 2007 | $0.00 | - |
FAQ
- What is Sunshine Biopharma annual accounts receivable?
- What is the all time high annual accounts receivable for Sunshine Biopharma?
- What is Sunshine Biopharma annual accounts receivable year-on-year change?
- What is Sunshine Biopharma quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly accounts receivable year-on-year change?
What is Sunshine Biopharma annual accounts receivable?
The current annual accounts receivable of SBFMW is $2.55 M
What is the all time high annual accounts receivable for Sunshine Biopharma?
Sunshine Biopharma all-time high annual accounts receivable is $2.55 M
What is Sunshine Biopharma annual accounts receivable year-on-year change?
Over the past year, SBFMW annual accounts receivable has changed by +$640.21 K (+33.48%)
What is Sunshine Biopharma quarterly accounts receivable?
The current quarterly accounts receivable of SBFMW is $3.22 M
What is the all time high quarterly accounts receivable for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly accounts receivable is $3.97 M
What is Sunshine Biopharma quarterly accounts receivable year-on-year change?
Over the past year, SBFMW quarterly accounts receivable has changed by $0.00 (0.00%)